[Serum thyroglobulin estimation for follow-up of patients with thyroid carcinoma (author's transl)].
Thyroglobulin concentrations were determined radioimmunologically in the sera of 53 patients operated for thyroid carcinoma. 37 patients without metastases or recurrence had either very low (up to maximally 15 ng/ml) or non-demonstrable thyroglobulin concentrations, whereas 16 patients with metastases showed values of more than 40 ng/ml up to maximal values of more than 1000 ng/ml. In the majority of patients follow-up controls, in part up to 2 years, were performed. A far-reaching conformity of thyroglobulin concentrations with scintigraphic or clinical findings of metastases was shown. Thyroglobulin estimation in operated thyroid cancer patients is thus an important contribution to the aftercare.
D000230:Adenocarcinoma / Q000097:blood; D002277:Carcinoma / Q000097:blood; D002291:Carcinoma, Papillary / Q000097:blood; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011182:Postoperative Care; D013954:Thyroglobulin / Q000097:blood*; D013964:Thyroid Neoplasms / Q000097:blood* / Q000601:surgery; D013997:Time Factors
D013954:Thyroglobulin
Serum-Thyreoglobulinbestimmung zur Verlaufskontrolle bei Schilddrüsenkarzinom-Patienten.